Skip to main content
Background Image and Headline States

Headline
Inspired by Hope.
Focused on Prevention.
Powered by Innovation.

Headline
Advancing the
Next Generation
of Revolutionary
Vaccines

Background Image and Headline States

Headline
Inspired by Hope.
Focused on Prevention.
Powered by Innovation.

Headline
Advancing the
Next Generation
of Revolutionary
Vaccines

Parent holding very young child, both wearing masks
Eyebrow
LATE-STAGE BIOTECHNOLOGY COMPANY
Main Content

About Novavax

We are committed to delivering novel products that leverage our innovative proprietary recombinant nanoparticle vaccine technology to prevent a broad range of infectious diseases. We produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats.

Image
Lab researcher measuring liquid into vials using a pipette
Call-to-action buttons

Never has our path forward been more clear or the need greater.

Stanley Erck
Main Content

Uniquely Qualified

“We will draw on our experience in developing vaccine candidates for some of the world’s toughest viral threats and use the power of our innovative recombinant nanoparticle vaccine platform, fortified by our Matrix-M™ adjuvant, to address an urgent need—to reduce the human toll of vaccine-preventable diseases.”

Stanley Erck
President and Chief Executive Officer
Novavax

Abstract image representing science and technology workflow
Eyebrow
Threats continually emerge and evolve
Main Content

An agile and determined team

Novavax scientists accelerate the development of new and promising vaccines by building on years of study and experience. Smart, talented, dedicated, and hardworking, they are driven by a passion to find answers and to solve some of our greatest health challenges.